Pfizer (XSWX:PFE) Other Operating Expense : CHF4,385 Mil (TTM As of Dec. 2023)

View and export this data going back to 1995. Start your Free Trial

What is Pfizer Other Operating Expense?

Pfizer's Other Operating Expense for the three months ended in Dec. 2023 was CHF1,096 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF4,385 Mil.

Pfizer's quarterly Other Operating Expense declined from Jun. 2023 (CHF1,066 Mil) to Sep. 2023 (CHF1,061 Mil) but then increased from Sep. 2023 (CHF1,061 Mil) to Dec. 2023 (CHF1,096 Mil).

Pfizer's annual Other Operating Expense declined from Dec. 2021 (CHF3,408 Mil) to Dec. 2022 (CHF3,362 Mil) but then increased from Dec. 2022 (CHF3,362 Mil) to Dec. 2023 (CHF4,093 Mil).

Pfizer Other Operating Expense Historical Data

The historical data trend for Pfizer's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Other Operating Expense Chart

Pfizer Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

4,351.94

2,974.36

3,407.70

3,362.15

4,093.10

Pfizer Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															1,020.83	1,066.07	1,060.63	1,095.70	1,162.29

Pfizer Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF4,385 Mil.

Pfizer Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Pfizer's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Pfizer (XSWX:PFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (XSWX:PFE) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

PFE:USA PFE:Peru PFE:Mexico PFE_KZ:Kazakhstan 1PFE:Italy PFEd:UK 0Q1N:UK PFE:Germany PFE:Chile PFE:Canada PFIZ34:Brazil PFE:Austria PFE:Argentina

Address

66 Hudson Boulevard East, New York, NY, USA, 10001-2192

Website

https://www.pfizer.com

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.